UPENN Biomedical Graduate Studies | Raiees Ahmad Andrabi

49 16

Raiees Ahmad Andrabi, PhD

Associate Professor of Medicine (Infectious Diseases)

7 5f

Department: Medicine

4 1 23

1f Graduate Group Affiliations 8

Immunology
Cell and Molecular Biology

46 Contact information
4d

Division of Infectious Diseases
23 Perelman School of Medicine
23 University of Pennsylvania
1d 522E Johnson Pavilion
35 3610 Hamilton Walk
Philadelphia, PA 19104

43 Lab: 215-573-5041
18

4 3 3 1d

18 Publications
23

5c 6f

26 Search PubMed for articles c

3 2 29

Links
a8 Search PubMed for articles
69 Andrabi Laboratory Website
c

4 b 1f

13 Education:
21 a B.Sc. 14 (Biology) c
3f University of Kashmir, Srinagar, India, 2005.
21 9 M.Sc 19 (Biochemistry) c
3d Hamdard University, New Delhi, India, 2007.
21 8 PhD 24 (Biochemistry/Philosophy) c
5a All India Institute of Medical Sciences (AIIMS) New Delhi, India, 2012.
c

3 3 3 3 92 Permanent link
2 29

92 SOM Home » BGS Home » Faculty a

1e 1d

Description of Research Expertise

2e6 A major focus in the Andrabi laboratory is to utilize in vitro directed evolution platform combined with structure-guided design approaches to develop vaccine immunogens against complex pathogens such as HIV, Influenza virus, Arenaviruses and Coronaviruses. The other major area of research in his laboratory is to understand the immunological basis of B cell affinity maturation pathways to complex antigen surfaces, both in vaccination and in infection and to utilize this information for designing more effective vaccines. The overall goal is to design vaccine immunogens and immunization strategies that can induce protective broadly neutralizing antibody responses against complex pathogens through vaccination in humans.
e 29

Selected Publications

21d Zhou P, Song G, He WT, Beutler N, Tse LV, Martinez DR, Schr A, Anzanello F, Yong P, Peng L, Dueker K, Musharrafieh R, Callaghan S, Capozzola T, Yuan M, Liu H, Limbo O, Parren M, Garcia E, Rawlings SA, Smith DM, Nemazee D, Jardine JG, Wilson IA, Safonova Y, Rogers TF, Baric RS, Gralinski LE, Burton DR, Andrabi R.: Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease. Immunity 56(3): 669–686, Mar 2023.

20c He WT, Musharrafieh R, Song G, Dueker K, Tse LV, Martinez DR, Sch�r A, Callaghan S, Yong P, Beutler N, Torres JL, Volk RM, Zhou P, Yuan M, Liu H, Anzanello F, Capozzola T, Parren M, Garcia E, Rawlings SA, Smith DM, Wilson IA, Safonova Y, Ward AB, Rogers TF, Baric RS, Gralinski LE, Burton DR, Andrabi R.: Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses. Nat Immunol 23(1): 960-970, June 2022.

1e9 Zhou P, Yuan M, Song G, Beutler N, Shaabani N, Huang D, He WT, Zhu X, Callaghan S, Yong P, Anzanello F, Peng L, Ricketts J, Parren M, Garcia E, Rawlings SA, Smith DM, Nemazee D, Teijaro JR, Rogers TF, Wilson IA, Burton DR, Andrabi R: A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Science Translational Medicine 14(637): 8, Feb 2022.

257 He WT, Yuan M, Callaghan S, Musharrafieh R, Song G, Silva M, Beutler N, Lee WH, Yong P, Torres JL, Melo M, Zhou P, Zhao F, Zhu X, Peng L, Huang D, Anzanello F, Ricketts J, Parren M, Garcia E, Ferguson M, Rinaldi W, Rawlings SA, Nemazee D, Smith DM, Briney B, Safonova Y, Rogers TF, Dan JM, Zhang Z, Weiskopf D, Sette A, Crotty S, Irvine DJ, Ward AB, Wilson IA, Burton DR, Andrabi R.: Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques. Sci Transl Med 14(657): eabl9605, Aug 2022.

1b6 Song G, He WT, Callaghan S, Anzanello F, Huang D, Ricketts J, Torres JL, Beutler N, Peng L, Vargas S, Cassell J, Parren M, Yang L, Ignacio C, Smith DM, Voss JE, Nemazee D, Ward AB, Rogers T, Burton DR, Andrabi R.: Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun 12(2938): 2938, May 2021.

199 Andrabi R, Pallesen J, Allen JD, Song G, Zhang J, de Val N, Gegg G, Porter K, Su CY, Pauthner M, Newman A, Bouton-Verville H, Garces F, Wilson IA, Crispin M, Hahn BH, Haynes BF, Verkoczy L, Ward AB, Burton DR.: The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template. Cell Rep 27(8): 2426-2441, May 2019.

d3 Andrabi R, Bhiman JN, Burton DR.: Strategies for a multi-stage neutralizing antibody-based HIV vaccine. Curr Opin Immunol 53(1), Aug 2018.

135 Andrabi R, Su CY, Liang CH, Shivatare SS, Briney B, Voss JE, Nawazi SK, Wu CY, Wong CH, Burton DR.: Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development. Immunity 47(3): 1004, Nov 2017.

1a9 Lee JH, Andrabi R, Su CY, Yasmeen A, Julien JP, Kong L, Wu NC, McBride R, Sok D, Pauthner M, Cottrell CA, Nieusma T, Blattner C, Paulson JC, Klasse PJ, Wilson IA, Burton DR, Ward AB.: A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic ?-Hairpin Structure. Immunity 46(4): 690-702, Apr 2017.

149 Andrabi R, Voss JE, Liang CH, Briney B, McCoy LE, Wu CY, Wong CH, Poignard P, Burton DR.: Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design. Immunity 43(5): 959-73, Nov 2015.

2c

7 1d

2c back to top
26 Last updated: 09/12/2024
34 The Trustees of the University of Pennsylvania c

1 49 2 8